Modified iRNA agents

Details for Australian Patent Application No. 2004233092 (hide)

International Classifications

Event Publications

1 December 2005 PCT application entered the National Phase

PCT publication WO2004/094595 Priority application(s): WO2004/094595

16 March 2006 Amendment Made

The nature of the amendment is: Amend the name of the applicant from Alnylam Pharmaceuticals Inc. to Alnylam Pharmaceuticals, Inc.

9 July 2009 Application Accepted

Published as AU-B-2004233092

17 September 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 26 Aug 2009. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

14 January 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 26 Aug 2009

21 January 2010 Standard Patent Sealed

18 March 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 08 Feb 2010. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

17 June 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 24 Mar 2010. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

5 August 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 08 Feb 2010 2005

11 November 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 24 Mar 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.